These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6226527

  • 41. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van der Schoot JB.
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [Abstract] [Full Text] [Related]

  • 42. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM.
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.
    Knop J, Kröger E, Stritzke P, Schneider C, Kruse HP.
    Eur J Nucl Med; 1981 Feb; 6(2):63-7. PubMed ID: 6451429
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ, Oliveri P, García del Río H, Labriola R, Artagaveytía D, Degrossi EB.
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The clinical comparison of skeletal imaging agents.
    Adams FG, Horton PW, Stenhouse G.
    Eur J Nucl Med; 1980 Jun; 5(3):257-60. PubMed ID: 6771137
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [A new bone scanning agent: clinical experience of 99mTc-hydroxymethane diphosphonate (HMDP) (author's transl)].
    Fukunaga M, Fujita T, Shigeno C, Morita R, Torizuka K.
    Kaku Igaku; 1981 Jul; 18(6):863-7. PubMed ID: 7311135
    [No Abstract] [Full Text] [Related]

  • 53. Diphosphonate bone scanning agents--current concepts.
    Fogelman I.
    Eur J Nucl Med; 1982 Jul; 7(11):506-9. PubMed ID: 6217074
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
    Arteaga de Murphy C, Meléndez-Alafort L, Montoya-Molina CE, Sepúlveda-Méndez J.
    Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.
    Kaye J, Hayward M.
    Australas Radiol; 2002 Mar; 46(1):13-21. PubMed ID: 11966582
    [Abstract] [Full Text] [Related]

  • 60. [Clinical evaluation of transaxial bone imaging with 99mTc-phosphate compounds].
    Yui N, Kinoshita F, Akiyama Y, Koakutsu M, Umeda T.
    Radioisotopes; 1982 Oct; 31(10):521-8. PubMed ID: 6221357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.